Search for products, methods, support...
Announcing NextSeq 1000 and NextSeq 2000.
Kits & Reagents
The power of high-throughput sequencing on a benchtop system with the v2.5 flow cell for greater stability and robustness
Selection & Planning Tools
Prepare sequencing libraries for small genomes, PCR amplicons, plasmids, or cDNA in as little as 90 minutes
Software & Informatics Products
Accurate, rapid analysis for germline and somatic exome experiments
Verify instrument installation and operation, obtain an audit-ready report
Find popular product groupings designed for your workflow
Generating RNA libraries from ultra-low-input samples
By Dr Phil Febbo, Chief Medical Officer at Illumina
All Investor Information
Upgrade solution for Illumina systems
All Support Tools
Product Support Services
Cancer Genomics Products
Microbial Genomics Research
Microbial Genomics Products
Complex Disease Research Products
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
Cost-efficient flexibility for new and emerging applications.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
A fast, integrated workflow for a wide range of applications, from human whole-genome sequencing to amplicons, plasmids, and microbial species.
Access a variety of NGS and array educational resources for clinical cancer research, including assorted videos and scientific papers.
Dr. Rahman reviews characteristics of known cancer predisposition genes and the potential prospects of future discoveries.
Nature Genetics presents the iCOGS Focus, which comprises a collection of 13 papers by the COGS Consortium.
Sequencing melanoma-prone family identified disease-segregating germline mutation in promoter of telomerase reverse transcriptase gene.
Jackson et al. demonstrate the use of high-density arrays to identify copy number changes in pediatric rhabdoid tumors.
Ho et al. identify 3 distinct subtypes of orbital meningioma via genetic profiling with microarrays.
Harada et al. use arrays to detect deletions and copy-neutral loss of heterozygosity.
Dr. Riazalhosseini at McGill University preserves the integrity of FFPE samples to analyze disease-causing mutations.
Dr. Navin at MD Anderson Cancer Center uses single-cell sequencing to analyze heterogeneity in tumor subpopulations.
Dr. Trilochan Sahoo, Director of Cytogenetics at Combimatrix, discusses array-based cytogenetic analysis for cancer.
Scientists at Cancer Genetics, Inc discuss how targeted NGS helps identify myeloid-related genes with greater sensitivity.
Deep analysis of exosomal DNA found in the blood of pancreatic cancer subjects offers insight into the potential of liquid biopsies.
A new enrichment-based cancer research assay interrogates both DNA and RNA, detecting small variants, gene amplifications, gene fusions, and splice variants.
Dr. Fellowes at Peter MacCallum Cancer Centre discusses how his team uses Illumina technology.
Nicholas J. Schork, PhD speaks about whole human genome variation, cancer driver mutations, and clinical sequencing.
Luis Diaz, MD at Johns Hopkins School of Medicine discusses using NGS to analyze ovarian and endometrial cancers.
Learn how comprehensive tumor profiling with NGS can help you avoid costly and time-consuming iterative testing.
Kenneth Bloom, MD, FCAP, Chief Medical Officer at Clarient (GE Healthcare) discusses the practical aspects of applying NGS in clinical research.
Visit our Medical Genetics website to download an introduction to NGS technology and applications for molecular pathologists.
View educational resources from recognized oncology experts and regulatory bodies about applying NGS in a clinical research setting.
View educational resources from recognized oncology experts and regulatory bodies about applying NGS in a clinical setting.
This is the international website for Illumina. If you are looking for information specific to your region, please select your location and we will redirect you.